Assort Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.50 M
- Company Age 15 Year, 5 Days
- Last Filing with ROC 31 Mar 2018
- Revenue Growth 37.98%
- Profit Growth 57.18%
- Ebitda 16.45%
- Net Worth 12.10%
- Total Assets 33.02%
About Assort Laboratories
Assort Laboratories Private Limited (ALPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 February 2010 and has a history of 15 years. Its registered office is in Patna, Bihar, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Mukul Singh, Umesh Sharma, and Himanshu Kumar serve as directors at the Company.
Company Details
- Location
Patna, Bihar, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230BR2010PTC015329
- Company No.
015329
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Feb 2010
- Date of AGM
30 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Who are the key members and board of directors at Assort Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Umesh Sharma  | Managing Director | 19-Feb-2010 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mukul Singh | Director | 19-Feb-2010 | Current |
| Himanshu Kumar | Director | 01-Apr-2013 | Current |
Financial Performance of Assort Laboratories.
Assort Laboratories Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 37.98% increase. The company also saw a substantial improvement in profitability, with a 57.18% increase in profit. The company's net worth Soared by an impressive increase of 12.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Assort Laboratories?
In 2018, Assort Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
_LIMITED.webp)
Printmart ( India) LimitedMukul Singh is a mutual person
Satyamev Developcon Private LimitedMukul Singh is a mutual person
- Anya Engicon Private Limited
Mukul Singh is a mutual person
- Gen X United Private Limited
Mukul Singh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Assort Laboratories?
Assort Laboratories has a workforce of 0 employees as of Mar 24, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Assort Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Assort Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
